Note 3 - Merger with Old Cytocom - Pro Forma Information (Details) - Cleveland BioLabs, Inc. [Member] - USD ($) |
9 Months Ended | |
|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Revenue | $ 2,437,139 | $ 1,665,992 |
| Net loss | $ (14,607,395) | $ (24,612,658) |
| X | ||||||||||
- Definition The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|